Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.
2.

What have we learned about how to measure quality of care for patients with community-acquired pneumonia?

Metersky ML, Abend SL, Meehan TP.

Respir Care Clin N Am. 2005 Mar;11(1):87-98. Review.

PMID:
15763224
3.

Community acquired bacterial pneumonia.

Anevlavis S, Bouros D.

Expert Opin Pharmacother. 2010 Feb;11(3):361-74. doi: 10.1517/14656560903508770. Review.

PMID:
20085502
4.

Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.

Niven DJ, Laupland KB.

Expert Rev Anti Infect Ther. 2009 Feb;7(1):69-81. doi: 10.1586/14787210.7.1.69. Review.

PMID:
19622058
5.

New guidelines for the management of adult community-acquired pneumonia.

Armitage K, Woodhead M.

Curr Opin Infect Dis. 2007 Apr;20(2):170-6. Review.

PMID:
17496576
6.

Impact of guidelines on outcome: the evidence.

Martínez R, Reyes S, Lorenzo MJ, Menéndez R.

Semin Respir Crit Care Med. 2009 Apr;30(2):172-8. doi: 10.1055/s-0029-1202936. Epub 2009 Mar 18. Review.

PMID:
19296417
7.

Evidence-based strategies for implementing guidelines in obstetrics: a systematic review.

Chaillet N, Dubé E, Dugas M, Audibert F, Tourigny C, Fraser WD, Dumont A.

Obstet Gynecol. 2006 Nov;108(5):1234-45. Review.

PMID:
17077251
8.

The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.

Ferrer M, Menendez R, Amaro R, Torres A.

Clin Chest Med. 2011 Sep;32(3):491-505. doi: 10.1016/j.ccm.2011.06.002. Review.

PMID:
21867818
9.

Community-acquired pneumonia.

Carbonara S, Monno L, Longo B, Angarano G.

Curr Opin Pulm Med. 2009 May;15(3):261-73. doi: 10.1097/MCP.0b013e3283287c3f. Review.

PMID:
19387263
10.
11.

Improving outcomes of elderly patients with community-acquired pneumonia.

Gutiérrez F, Masiá M.

Drugs Aging. 2008;25(7):585-610. Review.

PMID:
18582147
12.

The role of new therapies for severe community-acquired pneumonia.

Restrepo MI, Anzueto A.

Curr Opin Infect Dis. 2006 Dec;19(6):557-64. Review.

PMID:
17075331
13.

Fluoroquinolones in the management of community-acquired pneumonia.

Albertson TE, Dean NC, El Solh AA, Gotfried MH, Kaplan C, Niederman MS.

Int J Clin Pract. 2010 Feb;64(3):378-88. doi: 10.1111/j.1742-1241.2009.02239.x. Review.

PMID:
20456176
14.

Antimicrobial treatment of community-acquired pneumonia.

Restrepo MI, Anzueto A.

Clin Chest Med. 2005 Mar;26(1):65-73. Review.

PMID:
15802167
16.

Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study.

Ramírez JA; Community-Acquired Pneumonia Organization Investigators.

Semin Respir Crit Care Med. 2005 Dec;26(6):543-52. Review.

PMID:
16388426
17.

Japanese guidelines for the management of community-acquired pneumonia.

Yanagihara K, Kohno S, Matsusima T.

Int J Antimicrob Agents. 2001;18 Suppl 1:S45-8. Review.

PMID:
11574195
18.

Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.

Schouten JA, Prins JM, Bonten MJ, Degener J, Janknegt RE, Hollander JM, Jonkers RE, Wijnands WJ, Verheij TJ, Sachs AP, Kullberg BJ; Dutch Working Party on Antibiotic Policy.

Neth J Med. 2005 Sep;63(8):323-35. Review.

19.

Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.

Segreti J, House HR, Siegel RE.

Am J Med. 2005 Jul;118 Suppl 7A:21S-28S. Review.

PMID:
15993674
20.

[The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].

Matsushima T; Japanese Respiratory Society.

Nihon Rinsho. 2003 Feb;61 Suppl 2:677-81. Review. Japanese. No abstract available.

PMID:
12722300

Supplemental Content

Support Center